Skip to main navigation
Skip to search
Skip to main content
The Capital Region of Denmark's Research Portal Home
Help & FAQ
Dansk
English
Home
Hospitals/departments
Researchers
Research output
Activities
Prizes
Search by expertise, name or affiliation
Cathrine Lund Lorentzen
Herlev and Gentofte Hospital
,
Center for Cancer Immune Therapy (CCIT)
2021
2023
Research activity per year
Overview
Fingerprint
Network
Research output
(8)
Similar Profiles
(12)
If you made any changes in Pure these will be visible here soon.
Fingerprint
Dive into the research topics where Cathrine Lund Lorentzen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Nivolumab
100%
Indoleamine-Pyrrole 2,3,-Dioxygenase
94%
Subunit Vaccines
84%
Vaccines
82%
Melanoma
63%
T-Lymphocytes
46%
Arginase
45%
Tumor-Infiltrating Lymphocytes
44%
Cancer Vaccines
42%
Neoplasms
37%
Cell- and Tissue-Based Therapy
33%
Ligands
29%
Vaccination
29%
Prostatic Neoplasms
27%
Peptides
25%
Safety
22%
Messenger RNA
19%
B-Cell Lymphoma
18%
Therapeutics
15%
Progression-Free Survival
12%
Confidence Intervals
12%
Tumor Microenvironment
10%
Clinical Trials, Phase I
10%
Immunosuppressive Agents
9%
montanide ISA 51
9%
L-Lactate Dehydrogenase
9%
Arginine
9%
Blood Cells
8%
Terminology
7%
In Vitro Techniques
7%
Clinical Trials
7%
Clinical Studies
7%
Survival
6%
Response Evaluation Criteria in Solid Tumors
6%
Vaccine Potency
5%
Intraperitoneal Injections
5%
Clone Cells
5%
Active Immunotherapy
5%
Integrin alpha Chains
5%
